Taurisano, Paolo
Pergola, Giulio
Monda, Anna
Antonucci, Linda A.
Di Carlo, Pasquale
Piarulli, Francesco
Passiatore, Roberta
Papalino, Marco
Romano, Raffaella
Monaco, Alfonso
Rampino, Antonio
Bonvino, Aurora
Porcelli, Annamaria
Popolizio, Teresa
Bellotti, Roberto
Bertolino, Alessandro
Blasi, Giuseppe http://orcid.org/0000-0003-0878-1131
Funding for this research was provided by:
Fondazione CON IL SUD (2011-PDR-06)
National Alliance for Research on Schizophrenia and Depression (28935)
Ricerca Finalizzata (PE-2011-02347951)
Article History
First Online: 2 March 2020
Compliance with ethical standards
: All procedures performed in this study involving human participants have been approved by the University of Bari ethic committee and comply with the 1964 Helsinki declaration, its later amendments and comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Giuseppe Blasi received lecture fees from Jannsen and Lundbeck. Alessandro Bertolino is a stockholder of Hoffmann-La Roche Ltd. He has also received consulting fees from Biogen and lecture fees from Otsuka, Janssen, Lundbeck. Giulio Pergola has been the academic supervisor of a Roche collaboration grant (years 2015–16) that funded his and Antonio Rampino’s salary. Antonio Rampino has received travel fees from Lundbeck. All other authors have no biomedical financial interests and no potential conflicts of interest.